- Home
- PYXS vs RPTX Comparison
PYXS vs RPTX Comparison
Compare PYXS & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- RPTX
- Stock Information
- Founded
- PYXS 2018
- RPTX 2016
- Country
- PYXS United States
- RPTX Canada
- Employees
- PYXS N/A
- RPTX N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- PYXS Health Care
- RPTX Health Care
- Exchange
- PYXS Nasdaq
- RPTX Nasdaq
- Market Cap
- PYXS 66.3M
- RPTX 63.9M
- IPO Year
- PYXS 2021
- RPTX 2020
- Fundamental
- Price
- PYXS $1.17
- RPTX $1.41
- Analyst Decision
- PYXS Strong Buy
- RPTX Strong Buy
- Analyst Count
- PYXS 5
- RPTX 3
- Target Price
- PYXS $9.00
- RPTX $4.50
- AVG Volume (30 Days)
- PYXS 405.6K
- RPTX 94.4K
- Earning Date
- PYXS 08-13-2025
- RPTX 08-05-2025
- Dividend Yield
- PYXS N/A
- RPTX N/A
- EPS Growth
- PYXS N/A
- RPTX N/A
- EPS
- PYXS N/A
- RPTX N/A
- Revenue
- PYXS N/A
- RPTX $1,073,000.00
- Revenue This Year
- PYXS N/A
- RPTX N/A
- Revenue Next Year
- PYXS N/A
- RPTX N/A
- P/E Ratio
- PYXS N/A
- RPTX N/A
- Revenue Growth
- PYXS N/A
- RPTX N/A
- 52 Week Low
- PYXS $0.83
- RPTX $0.89
- 52 Week High
- PYXS $5.39
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- PYXS 46.51
- RPTX 51.83
- Support Level
- PYXS $1.14
- RPTX $1.33
- Resistance Level
- PYXS $1.41
- RPTX $1.48
- Average True Range (ATR)
- PYXS 0.08
- RPTX 0.05
- MACD
- PYXS -0.02
- RPTX -0.01
- Stochastic Oscillator
- PYXS 12.73
- RPTX 34.37
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.